Hepatitis C vaccine - Bavarian Nordic
Alternative Names: MVA-BN HCVLatest Information Update: 24 May 2007
At a glance
- Originator Bavarian Nordic
- Class Hepatitis C vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 24 May 2007 Discontinued - Preclinical for Hepatitis C in Denmark (unspecified route)
- 24 May 2007 Discontinued - Preclinical for Hepatitis C in Germany (unspecified route)
- 09 Jan 2004 No development reported - Preclinical for Hepatitis C in Denmark (unspecified route)